Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2008
11/13/2008US20080280967 Antiarthritic agents; antiinflammatory agents; inflammatory bowel disorders; graft verses host disease; antiulcer agents; skin disorders; respiratory system disorders; anticancer agents
11/13/2008US20080280965 Novel tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCPs)
11/13/2008US20080280958 Administering a phosphodiesterase inhibitor; bioavailability; skin disorders; respiratory system disorders; using roflumilast
11/13/2008US20080280952 Pyridine Derivatives as Connabinoid Receptor Modulators
11/13/2008US20080280950 Hydantoin Derivatives Useful as Metalloproteinase Inhibitors
11/13/2008US20080280941 8-Phenoxy-Gamma Carboline Derivatives
11/13/2008US20080280939 Combination of Organic Compounds
11/13/2008US20080280926 Phosphodiesterase Inhibitors
11/13/2008US20080280918 phosphodiesterase enzyme inhibitor; 4-[(3-chlorophenyl)amino]-2-ethyl-5-(1-hydroxyethyl)-6-phenylpyridazin-3(2H)-one; potent antiinflammatory agent; asthma, atopic dermatitis, psoriasis, chronic obstructive pulmonary disease, rheumatoid arthritis, irritable bowel disease
11/13/2008US20080280901 Pharmaceutical Composition for Preventing and Treating Metabolic Bone Diseases Containing Alpha-Arylmethoxyacrylate Derivatives
11/13/2008US20080280863 Concurrent administering by mouth a corticosteroid and tricyclic antidepressant compound; immunoinflamamtory disorders; antiarthritic agents; skin disorders; inflammatory bowel disorders; Crohn's disorders; autoimmune disease; asthma; multiple sclerosis; diabetes; lupus
11/13/2008US20080280862 Methods, compositions, and kits for the treatment of pain
11/13/2008US20080280829 Inhibition of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2); osteoporosis, osteopenia; use of 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)-aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one
11/13/2008US20080280308 G protein coupled receptor signaling modulation
11/13/2008US20080279969 Composition Comprising Bamboo Extract for Androgen Agonist
11/13/2008US20080279958 Snake venom compositions and methods of use
11/13/2008US20080279941 Hydrogel substrate with porous surfaces; attaching biomaterials to living tissue; load bearing inserts; tissue repair and regeneration; disk prosthetics
11/13/2008US20080279934 Multilayer tablet ; autoimmune disease; antidiabetic agents; rheumatic disorders; antiarthritic agents; psoriasis
11/13/2008US20080279932 Vildagliptin salt; in mixture with therapeutic agents such as antidiabetic agents; antilipemic agents; obesity; appetite control; hypotensive agents; cholesterol absorption moderators; anticoagulants; estrogen receptor moderators; transferring across blood-brain barrier
11/13/2008US20080279908 Hydroxyapatite-Binding Peptides for Bone Growth and Inhibition
11/13/2008US20080279857 Therapeutic Agent
11/13/2008US20080279841 Novel Therapeutic Molecular Variants And Uses Thereof
11/13/2008US20080279832 Osteogenic differentiation of preosteoblastic cells
11/13/2008US20080279822 Crystalline Polymorphs of a CXC-Chemokine Receptor Ligand
11/13/2008DE102007022694A1 Milchfett-Milchprotein-Zusammensetzung zur Verbesserung der Calcium-Aufnahme Milk fat Milk Protein composition for improving the calcium uptake
11/13/2008CA2689608A1 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation
11/13/2008CA2685956A1 A method for treating inflammation and controlled-release material capable of providing same
11/13/2008CA2685389A1 Tricyclic compounds as matrix metalloproteinase inhibitors
11/13/2008CA2684703A1 Bicyclic compound and pharmaceutical use thereof
11/12/2008EP1990413A1 Screening method for candidate drugs
11/12/2008EP1990343A2 Azaindoles
11/12/2008EP1989295A1 A method for osteogenic differentiation of bone marrow stem cells (bmsc) and uses thereof
11/12/2008EP1989200A2 [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases
11/12/2008EP1646634B1 Use of rapamycin and rapamycin derivatives for the treatment of bone loss
11/12/2008EP1644340B1 N-[({'4-substituted piperazine-1-yl}sulfonylmethyl)alkyl]-n-hydroxyformamide compounds as metalloproteinase inhibitors
11/12/2008EP1549648B1 Bicyclic heteroaromatic compounds as kinase inhibitors
11/12/2008EP1523488B1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
11/12/2008EP1436321B9 Synthesis of cyclosporin analogs
11/12/2008EP1424894B1 Inhibition of pathological angiogenesis in vivo
11/12/2008CN101302515A Human antibodies that bind human TNF(alpha)
11/12/2008CN101302501A PEGylated uricoxidase compound, preparing method, preparation and use thereof
11/12/2008CN101302467A Tuckahoe wine
11/12/2008CN101302242A Novel use of ecdysterone
11/12/2008CN101301460A Rheumatism paste for resolving stasis
11/12/2008CN101301459A Medicated pillow
11/12/2008CN101301452A Medicinal composition for treating gout and rheumatism
11/12/2008CN101301448A Prescription for treating osteoproliferation and preparation method thereof
11/12/2008CN101301445A External-use powder for treating dermatopathy and paralysis
11/12/2008CN101301435A External-use medicament for treating bony spur
11/12/2008CN101301434A Chinese medicinal composition for treating cervical vertebra disease
11/12/2008CN101301407A Medicament for treating arthritis and angiitis
11/12/2008CN101301406A Externally applied agent for treating hyperosteogeny, disc herniation, cervical vertebra inflammation and rheumathritis
11/12/2008CN101301394A Medicament for treating rheumatoid disease
11/12/2008CN101301392A Chinese medicine for treating systemic lupus erythematosus and preparation thereof
11/12/2008CN101301379A Chinese medicinal composition and preparation and use thereof
11/12/2008CN101301372A Medicament for treating osteoproliferation
11/12/2008CN101301369A Medicament for treating cervical vertebra and/or lumbar diseases
11/12/2008CN101301350A Lamioplomis rotate extract oral freeze-dried tablet and preparation thereof
11/12/2008CN101301343A Chinese medicine paste for promoting healing of bone fracture
11/12/2008CN101301329A Application of plant extract for preparing medicine to cure bone absorption increment diseases and composition thereof
11/12/2008CN100432107C Protein for promoting erythrocyte growth factor activity and its use
11/12/2008CN100432062C Terphenyl derivatives, preparation thereof, compositions containing same
11/12/2008CN100432055C Tricyclic protein kinase inhibitors
11/12/2008CN100431604C C1 inhibitor with short half-life for transient treatment
11/12/2008CN100431588C Preparation of Chinese traditional medicine for treating disease of prolapse of intervertebral disc
11/12/2008CN100431576C Chinese materia medica preparation for treating pain in waist and lower extremities, and preparaton method
11/12/2008CN100431547C A triptolide composite preparation for treating osteoarthritis by joint intracavity injection
11/12/2008CN100431545C Use of compositions comprising an estrogenic component for the treatment and prevention of musculoskeletal pain
11/12/2008CN100431533C Medicinal composition containing backuchiol for treating female osteoporosis
11/11/2008US7449581 6-Substituted pyrido-pyrimidines
11/11/2008US7449572 Reducing compound such as 3,3-ethylenedioxyestra-5(10), 9(11)-dien-17-ol, halogenating, epoxidation, alkylation, deprotecting, aromatization, saponification, neutralization to obtain compound such as 11-beta-(4-(2-(1-piperidinyl)ethoxy)phenyl)-17-alpha-fluoroestra-1,3,5(10)-trien-3-ol
11/11/2008US7449557 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
11/11/2008US7449495 e.g. 4-(3-(1-Adamantyl)-4-tert-butyldimethyl-silyloxyphenyl)benzaldehyde; antitumor, antiinflammatory agent; arthritic pathology, metastatisation, diabetic retinopathy, psoriasis, chronic inflammatory disease, and atherosclerosis; sarcoma, carcinoma, carcinoid, leukaemia
11/11/2008US7449493 N-[2-[[1-[[[(2,4-dimethylphenyl)methyl]amino]methyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide; monocyte chemoattractant proteins receptor antagonists or partial agonists/antagonists; antiinflammatory agent, autoimmune diseases; rheumatoid arthritis, multiple sclerosis, atherosclerosis
11/11/2008US7449492 Therapeutic agents—I
11/11/2008US7449487 In particular of avocado, soya bean and/or lupin oils, for preparation of a medicament intended to stimulate expression of TGF-62 or expression of the plasminogen activator inhibitor PAI-1
11/11/2008US7449484 angiogenesis inhibitor; Tie2 receptor kinase inhibitors; 2-tert-Butyl-4-naphthalen-2-yl-5-pyridin-4-yl-imidazole;2-tert-Butyl-4-(6-Ethoxynaphthalen-2-yl)-5-pyridin-4-yl-imidazole;4-(2-tert-Butyl-5-(6-methoxy-naphthalen-2-yl)-3H-imidazol-4-yl)-pyridine; etc.
11/11/2008US7449475 e.g. 2-{[(2S)-3-(5-Chloro-1'H,3H-spiro[1-benzofuran-2,4'-piperidin]-1'-yl)-2-hydroxypropyl]oxy}-N-cyclopropylbenzamide; macrophage inflammatory protein (MIP)-1 alpha chemokine receptor modulator; antiinflammatory, antiproliferative agent, autoimmune diseases
11/11/2008US7449472 Methods of inhibiting p38 with substituted bicyclic pyrimidines
11/11/2008US7449455 1-[4-(2-azepan-1-yl-ethoxy)-benzyl]-2-(4-hydroxy-phenyl)-3-methyl-1H-indol-5-ol; contraception; melanoma; capable of inhibiting bone loss while showing little or no uterine stimulation, decrease the weight gain, decrease cholesterol levels, prevent bone loss
11/11/2008US7449324 Determining in a sample of an animal the presence of a viral component by reacting the sample with a nucleic acid or an antibody reactive with component of an avian pneumovirus, and crossreactive with a component of MPV (metapneumovirus)
11/11/2008US7449198 Stable salts of O-acetylsalicylic acid with basic amino acids
11/11/2008US7449185 Immunoglobulin which binds osteoclastogenesis inhibitory factor binding molecules (OBM)) and prevents bone resorption for use in treatment and prevention of bone disorders
11/11/2008CA2588369A1 Methods of treatment and prevention of metabolic bone diseases and disorders
11/06/2008WO2008134513A2 Copper lowering treatment of autoimmune diseases
11/06/2008WO2008134300A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
11/06/2008WO2008133192A1 Fused imidazole compound and use thereof
11/06/2008WO2008132846A1 Tricyclic heteroaryl compound
11/06/2008WO2008132458A1 Compositions useful in the modulation of immune responses and the treatment or prevention of inflammatory responses and related methods
11/06/2008WO2008132453A1 Antibodies against ramp3
11/06/2008WO2008132025A1 Use of 4-(nitrooxy)-butyl-(s)-2-(6-methoxy-2-naphtyl)-propanoate for treating pain and inflammation
11/06/2008WO2008131599A1 T-cell receptor vaccines materials and methods
11/06/2008WO2008131586A1 Uses of 5-methyl-1-(substituted phenyl)-2(1h)-pyridones as anti-inflammatory and tnf-alpha-blocking agents
11/06/2008WO2008100567A3 Thrombin peptide derivatives for treating fractures in osteopenic patients
11/06/2008WO2008073395A3 Compositions and methods for cardiac tissue protection and regeneration
11/06/2008WO2008009476A3 Concentrated methotrexate solutions
11/06/2008WO2007064618A8 Methods for the treatment of muscle loss
11/06/2008US20080275127 Arylsulfonamido-substituted hydroxamic acid derivatives
11/06/2008US20080275117 Compositions and Methods Comprising Boswellia Species
11/06/2008US20080275108 VACUOLAR-TYPE (H+)-ATPase-INHIBITING COMPOUNDS, COMPOSITIONS, AND USES THEREOF
1 ... 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 ... 820